Literature DB >> 28411046

Different influence of antipsychotics on the balance between pro- and anti-inflammatory cytokines depends on glia activation: An in vitro study.

Ewa Obuchowicz1, Anna M Bielecka-Wajdman2, Monika Paul-Samojedny3, Marta Nowacka4.   

Abstract

The microglial hypothesis of schizophrenia suggests that its neuropathology is closely associated with neuroinflammation manifested, inter alia, by an increased expression of cytokines. However, clinical investigations imply that schizophrenia is a heterogeneous disease and in some groups of patients the activated inflammatory process does not contribute to the disease-associated impairment of brain function. Clinical studies revealed also an equivocal impact of antipsychotics on peripheral and CSF cytokines, whereas experimental research performed on the stimulated glia cultures showed their inhibitory effect on pro-inflammatory cytokine levels. In the present study, the effect of chlorpromazine, haloperidol and risperidone (0.5, 5 or 10μM) on production of pro-inflammatory cytokines IL-1β and TNF-α and anti-inflammatory IL-10 was investigated in the unstimulated and lipopolysaccharide-stimulated primary rat mixed glial cell cultures. In the unstimulated cultures, haloperidol at all applied concentrations, risperidone at 5, 10μM and chlorpromazine at 10μM increased IL-10 levels in the culture supernatants without a significant influence on IL-1β or TNF-α levels, and all drugs applied at 10μM induced a robust increase in IL-10 mRNA expression. Under strong inflammatory activation, haloperidol and risperidone at all concentrations reduced production of both pro-inflammatory cytokines, without adverse effects on IL-10 expression when used at 10μM. Chlorpromazine at all concentrations diminished the production of three cytokines and did not induce anti-inflammatory effect. These results suggest that dependently on glia activation antipsychotics via different mechanisms may induce anti-inflammatory effect and that this activity is not common for all drugs under conditions of strong glia activation.
Copyright © 2017. Published by Elsevier Ltd.

Entities:  

Keywords:  Antipsychotics; Cytokines; Unstimulated and LPS-stimulated rat primary mixed glial cell cultures

Mesh:

Substances:

Year:  2017        PMID: 28411046     DOI: 10.1016/j.cyto.2017.04.004

Source DB:  PubMed          Journal:  Cytokine        ISSN: 1043-4666            Impact factor:   3.861


  12 in total

Review 1.  Immune Abnormalities in Autism Spectrum Disorder-Could They Hold Promise for Causative Treatment?

Authors:  Dominika Gładysz; Amanda Krzywdzińska; Kamil K Hozyasz
Journal:  Mol Neurobiol       Date:  2018-01-06       Impact factor: 5.590

Review 2.  Roles of inflammation in intrinsic pathophysiology and antipsychotic drug-induced metabolic disturbances of schizophrenia.

Authors:  Tyler R Prestwood; Roshanak Asgariroozbehani; Sally Wu; Sri Mahavir Agarwal; Ryan W Logan; Jacob S Ballon; Margaret K Hahn; Zachary Freyberg
Journal:  Behav Brain Res       Date:  2021-01-14       Impact factor: 3.332

3.  Association Between FIASMAs and Reduced Risk of Intubation or Death in Individuals Hospitalized for Severe COVID-19: An Observational Multicenter Study.

Authors:  Nicolas Hoertel; Marina Sánchez-Rico; Erich Gulbins; Johannes Kornhuber; Alexander Carpinteiro; Eric J Lenze; Angela M Reiersen; Miriam Abellán; Pedro de la Muela; Raphaël Vernet; Carlos Blanco; Céline Cougoule; Nathanaël Beeker; Antoine Neuraz; Philip Gorwood; Jesús M Alvarado; Pierre Meneton; Frédéric Limosin
Journal:  Clin Pharmacol Ther       Date:  2021-07-02       Impact factor: 6.903

4.  Overexpression Of miR138 Ameliorates Spared Sciatic Nerve Injury-Induced Neuropathic Pain Through The Anti-Inflammatory Response In Mice.

Authors:  Benfan Zhu; Jie Gao; Yeling Ouyang; Zhiqiang Hu; Xiangdong Chen
Journal:  J Pain Res       Date:  2019-11-18       Impact factor: 3.133

5.  Clozapine Prevents Poly (I:C) Induced Inflammation by Modulating NLRP3 Pathway in Microglial Cells.

Authors:  Vijayasree V Giridharan; Giselli Scaini; Gabriela D Colpo; Tejaswini Doifode; Omar F Pinjari; Antônio L Teixeira; Fabricia Petronilho; Danielle Macêdo; João Quevedo; Tatiana Barichello
Journal:  Cells       Date:  2020-02-28       Impact factor: 6.600

6.  Aripiprazole as a Candidate Treatment of COVID-19 Identified Through Genomic Analysis.

Authors:  Benedicto Crespo-Facorro; Miguel Ruiz-Veguilla; Javier Vázquez-Bourgon; Ana C Sánchez-Hidalgo; Nathalia Garrido-Torres; Jose M Cisneros; Carlos Prieto; Jesus Sainz
Journal:  Front Pharmacol       Date:  2021-03-02       Impact factor: 5.810

7.  Dopamine activates NF-κB and primes the NLRP3 inflammasome in primary human macrophages.

Authors:  R A Nolan; K L Reeb; Y Rong; S M Matt; H S Johnson; K Runner; P J Gaskill
Journal:  Brain Behav Immun Health       Date:  2019-12-31

8.  Changes in peripheral blood compounds following psychopharmacological treatment in drug-naïve first-episode patients with either schizophrenia or major depressive disorder: a meta-analysis.

Authors:  Nuray Çakici; Arjen L Sutterland; Brenda W J H Penninx; Lieuwe de Haan; Nico J M van Beveren
Journal:  Psychol Med       Date:  2021-03-03       Impact factor: 7.723

Review 9.  Therapeutic Drug Monitoring of Second- and Third-Generation Antipsychotic Drugs-Influence of Smoking Behavior and Inflammation on Pharmacokinetics.

Authors:  Nicole Moschny; Gudrun Hefner; Renate Grohmann; Gabriel Eckermann; Hannah B Maier; Johanna Seifert; Johannes Heck; Flverly Francis; Stefan Bleich; Sermin Toto; Catharina Meissner
Journal:  Pharmaceuticals (Basel)       Date:  2021-05-27

10.  Sex-Specific Cannabidiol- and Iloperidone-Induced Neuronal Activity Changes in an In Vitro MAM Model System of Schizophrenia.

Authors:  Rachel-Karson Thériault; Myles St-Denis; Tristen Hewitt; Jibran Y Khokhar; Jasmin Lalonde; Melissa L Perreault
Journal:  Int J Mol Sci       Date:  2021-05-24       Impact factor: 5.923

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.